- Home
- GLRE vs PACB Comparison
GLRE vs PACB Comparison
Compare GLRE & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLRE
- PACB
- Stock Information
- Founded
- GLRE 2004
- PACB 2000
- Country
- GLRE Cayman Islands
- PACB United States
- Employees
- GLRE N/A
- PACB N/A
- Industry
- GLRE Property-Casualty Insurers
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- GLRE Finance
- PACB Industrials
- Exchange
- GLRE Nasdaq
- PACB Nasdaq
- Market Cap
- GLRE 471.2M
- PACB 452.1M
- IPO Year
- GLRE 2007
- PACB 2010
- Fundamental
- Price
- GLRE $14.50
- PACB $1.60
- Analyst Decision
- GLRE
- PACB Buy
- Analyst Count
- GLRE 0
- PACB 15
- Target Price
- GLRE N/A
- PACB $2.92
- AVG Volume (30 Days)
- GLRE 92.1K
- PACB 11.4M
- Earning Date
- GLRE 11-04-2024
- PACB 11-07-2024
- Dividend Yield
- GLRE N/A
- PACB N/A
- EPS Growth
- GLRE N/A
- PACB N/A
- EPS
- GLRE 2.53
- PACB N/A
- Revenue
- GLRE $702,254,000.00
- PACB $173,147,000.00
- Revenue This Year
- GLRE N/A
- PACB N/A
- Revenue Next Year
- GLRE N/A
- PACB $25.88
- P/E Ratio
- GLRE $5.73
- PACB N/A
- Revenue Growth
- GLRE 8.96
- PACB 2.14
- 52 Week Low
- GLRE $10.68
- PACB $1.16
- 52 Week High
- GLRE $15.82
- PACB $10.65
- Technical
- Relative Strength Index (RSI)
- GLRE 57.86
- PACB 36.99
- Support Level
- GLRE $14.36
- PACB $1.82
- Resistance Level
- GLRE $15.82
- PACB $2.66
- Average True Range (ATR)
- GLRE 0.41
- PACB 0.34
- MACD
- GLRE 0.05
- PACB -0.08
- Stochastic Oscillator
- GLRE 50.93
- PACB 3.02
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed, and income from investments.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.